Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q2 2025 Earnings Call Transcript August 6, 2025
Lexicon Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.00894, expectations were $-0.08.
Operator: Welcome to the Lexicon Pharmaceuticals Second Quarter 2025 Financial Results Conference Call. [Operator Instructions] As a reminder, this call is being recorded today, August 6, 2025. I will now turn the call over to Lisa DeFrancesco, SVP, Investor Relations and Corporate...
